Addressing intersectional stigma through coping, resistance, and resilience to improve methamphetamine use and factors influencing PrEP uptake among Latino MSM: a step towards ending HIV by 2030
Project Number5K01DA055521-03
Former Number1K01DA055521-01
Contact PI/Project LeaderALGARIN, ANGEL B
Awardee OrganizationARIZONA STATE UNIVERSITY-TEMPE CAMPUS
Description
Abstract Text
220.7 PROJECT SUMMARY/ABSTRACT
Stigma is a main driver of HIV disparities among Latino men who have sex with men (LMSM), negatively affecting
non-injection substance use (e.g. methamphetamine) and PrEP uptake. Addressing factors that influence PrEP
cascade progression, such as intersectional stigma and methamphetamine use, are essential to ending the HIV
epidemic. Intersectional stigma is a complex social phenomenon experienced across various stigma sources
(i.e. family, friends, others), mechanisms (i.e. anticipated, enacted), and types (i.e. race/ethnicity, sexuality,
masculinity), which intersect to produce and exacerbate deleterious health outcomes among LMSM. Social
network analysis techniques can be leveraged to examine how LMSM interact with and are affected by network
members and inform targets for meaningful interventions focused on which network members (1) stigmatize
LMSM and (2) provide social support to buffer against the effects of intersectional stigma on methamphetamine
use risk and PrEP cascade progression.
This K01 will provide the candidate, Dr. Algarin, with skills to conduct complex longitudinal multi-level structural
equation modeling to examine the direct and indirect effects between intersectional stigma and
methamphetamine use risk and PrEP cascade progression through coping, resistance, and resilience (AIM 1)
and how sources of social network intersectional stigma moderate these pathways (AIM 2) leveraging data from
500 LMSM enrolled in NEXUS: a novel social network approach to study the effects of intersectional stigma on
HIV prevention among Latino MSM (NEXUS; R01MH123282; PI: Smith). Using a community-engaged
approach, Dr. Algarin will draw from these analyses to adapt a multi-level intervention to address intersectional
stigma through coping, resistance, and resilience to decrease methamphetamine use risk and improve PrEP
cascade progression (AIM 3).
As an emerging gay Latino scholar, Dr. Algarin will leverage the UCSD training infrastructure to build his
professional independence and skills to promote HIV prevention interventions in medically marginalized groups,
positioning him as the next generation of under-represented minority scholars to end the HIV epidemic among
MSM of color disproportionately burdened by HIV in the US. Specifically, Dr. Algarin seeks training to advance
his statistical capacities (T1), gain proficiency multi-level intervention theories and concepts (T2) and multi-level
intervention development and adaptation (T3), gain additional training in the ethical conduct of research (T4),
and build skills for his professional development (T5). This K01 will provide Dr. Algarin with the necessary training
and data to forge his research independence and produce a competitive future R34 to test the community-
engaged, multi-level intervention he adapts as part of this study.
Public Health Relevance Statement
220.8 PROJECT NARRATIVE
Latino men who have sex with men (LMSM) face one of the largest disparities in new HIV diagnoses nationally,
likely because they face intersectional stigma towards their ethnic, sexual, and gender identities (i.e. adherence
to masculinity norms) which negatively affects both methamphetamine use and PrEP cascade progression.
Social network analysis employing longitudinal multilevel structural equation modeling is an innovative method
for studying how intersectional stigma is experienced by members of LMSM’s social network and can
differentiate between which network members and under what social contexts stigma reduction interventions
could decrease methamphetamine use risk and improve PrEP cascade progression to reduce HIV incidence.
Through this K01, Dr. Algarin will leverage the UCSD training infrastructure to build his professional
independence and skills for promoting HIV prevention in medically marginalized groups, positioning him as a
leader among the next generation of under-represented minority scholars to end the HIV epidemic among MSM
of color disproportionately burdened by HIV in the US.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AIDS preventionAddressAdherenceAffectBehaviorBuffersColorCommunitiesComplexDataDevelopmentDisparityEnrollmentEpidemicEquationEthicsEthnic OriginFaceFamilyFamily memberFriendsFutureGaysGender IdentityGoalsHIVHIV InfectionsHIV diagnosisHIV disparitiesHIV riskHealthHuman immunodeficiency virus testIncidenceInterventionLaboratoriesLatinoLinkMediationMediatorMedicalMethamphetamineMethodsModelingNIH Office of AIDS ResearchOutcomePathway AnalysisPathway interactionsPositioning AttributeProcessRaceResearchResearch PriorityResistanceRiskRisk BehaviorsSexualitySocial EnvironmentSocial NetworkSocial supportSourceStigmatizationTechniquesTestingTrainingTraining and InfrastructureUnderrepresented Minoritycommunity engaged approachcommunity engaged interventioncommunity engagementcopingcultural valuesethnic identityexperienceforgingimprovedinnovationmarginalized populationmembermen who have sex with menmethamphetamine usenext generationnovelpre-exposure prophylaxispreventive interventionprospectiveresiliencesexual identityskillssocialsocial stigmastimulant usesubstance usetheoriestherapy developmentuptake
No Sub Projects information available for 5K01DA055521-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5K01DA055521-03
Patents
No Patents information available for 5K01DA055521-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5K01DA055521-03
Clinical Studies
No Clinical Studies information available for 5K01DA055521-03
News and More
Related News Releases
No news release information available for 5K01DA055521-03
History
No Historical information available for 5K01DA055521-03
Similar Projects
No Similar Projects information available for 5K01DA055521-03